These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24746914)

  • 1. Recommendations for the use of methotrexate in rheumatoid arthritis: up and down scaling of the dose and administration routes.
    Tornero Molina J; Ballina García FJ; Calvo Alén J; Caracuel Ruiz MÁ; Carbonell Abelló J; López Meseguer A; Moreno Muelas JV; Pérez Sandoval T; Quijada Carrera J; Trenor Larraz P; Zea Mendoza A
    Reumatol Clin; 2015; 11(1):3-8. PubMed ID: 24746914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms.
    Cipriani P; Ruscitti P; Carubbi F; Liakouli V; Giacomelli R
    Clin Ther; 2014 Mar; 36(3):427-35. PubMed ID: 24612941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing methotrexate therapy in rheumatoid arthritis: a systematic literature review.
    Mouterde G; Baillet A; Gaujoux-Viala C; Cantagrel A; Wendling D; Le Loët X; Schaeverbeke T
    Joint Bone Spine; 2011 Dec; 78(6):587-92. PubMed ID: 21444233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis.
    Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; Khanna S; Singh S
    Clin Ther; 2014 Jul; 36(7):1005-15. PubMed ID: 24976447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature.
    Visser K; van der Heijde D
    Ann Rheum Dis; 2009 Jul; 68(7):1094-9. PubMed ID: 19033290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
    Bannwarth B; Péhourcq F; Schaeverbeke T; Dehais J
    Clin Pharmacokinet; 1996 Mar; 30(3):194-210. PubMed ID: 8882301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eficiency of different doses of rituximab in rheumatoid arthritis.
    Mena-Vázquez N; Manrique-Arija S; Ureña-Garnica I; Romero-Barco CM; Jiménez-Núñez FG; Coret V; Irigoyen-Oyarzábal MV; Fernández-Nebro A
    Reumatol Clin; 2016; 12(3):139-45. PubMed ID: 26458761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal administration and dosage of methotrexate.
    Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S46-51. PubMed ID: 21044433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.
    Hobl EL; Mader RM; Jilma B; Duhm B; Mustak M; Bröll H; Högger P; Erlacher L
    Clin Ther; 2012 May; 34(5):1195-203. PubMed ID: 22516039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate in patients with rheumatoid arthritis in Spain: Subanalysis of the AR Excellence project.
    Tornero-Molina J; Andreu JL; Martín-Martínez MA; Corominas H; Pérez Venegas JJ; Román-Ivorra JA; Sánchez-Alonso F
    Reumatol Clin (Engl Ed); 2019; 15(6):338-342. PubMed ID: 29273497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion.
    Pavy S; Constantin A; Pham T; Gossec L; Maillefert JF; Cantagrel A; Combe B; Flipo RM; Goupille P; Le Loët X; Mariette X; Puéchal X; Schaeverbeke T; Sibilia J; Tebib J; Wendling D; Dougados M
    Joint Bone Spine; 2006 Jul; 73(4):388-95. PubMed ID: 16626993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.
    Smolen JS; van Vollenhoven R; Kavanaugh A; Strand V; Vencovsky J; Schiff M; Landewé R; Haraoui B; Arendt C; Mountian I; Carter D; van der Heijde D
    Arthritis Res Ther; 2015 Sep; 17(1):245. PubMed ID: 26353833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review.
    Durán J; Bockorny M; Dalal D; LaValley M; Felson DT
    Ann Rheum Dis; 2016 Sep; 75(9):1595-8. PubMed ID: 27091836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial).
    Verstappen SM; Jacobs JW; van der Veen MJ; Heurkens AH; Schenk Y; ter Borg EJ; Blaauw AA; Bijlsma JW;
    Ann Rheum Dis; 2007 Nov; 66(11):1443-9. PubMed ID: 17519278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB; von Kempis J; Haile SR; Schiff MH
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis.
    Wegrzyn J; Adeleine P; Miossec P
    Ann Rheum Dis; 2004 Oct; 63(10):1232-4. PubMed ID: 15361377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate.
    Takeuchi T; Matsubara T; Nitobe T; Suematsu E; Ohta S; Honjo S; Abe T; Yamamoto A; Miyasaka N;
    Mod Rheumatol; 2013 Mar; 23(2):226-35. PubMed ID: 22684431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial.
    Fleischmann RM; Cohen SB; Moreland LW; Schiff M; Mease PJ; Smith DB; Keenan G; Kremer JM;
    Curr Med Res Opin; 2005 Aug; 21(8):1181-90. PubMed ID: 16083527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.